MYBPC3 and hypertrophic cardiomyopathy: Exosomes from patients with hypertrophic cardiomyopathy have been found to contain cMyBP-C, indicating the possibility that this molecule could serve as a biomarker for the condition (Gao et al., 2022[38]).